| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Apr | Jun » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
May 21st, 2012 tmccoy
by: Michael Werner, Esq. Recently the U.S. Food and Drug Administration (“FDA”) for the first time a Plavix is a blood thinner prescribed for the prevention of blood clots, and is often the preferred treatment for patients particularly at risk of suffering a stroke or heart attack. The drug has been linked to serious side [...]
May 21st, 2012 tmccoy
by: Michael Werner, Esq. The U.S. Food and Drug Administration (“FDA”) has recently notified healthcare professionals that it is reviewing the results of a New England Journal of Medicine study that suggests that Zithromax (azithromycin) users are at a heightened risk of suffering cardiovascular death. Zithromax is an antibacterial drug used to treat a variety [...]
May 21st, 2012 tmccoy
by: Stephanie Herschaft, Esq. Last month, Health Canada became the latest national drug regulator to issue a warning regarding the connection Actos and bladder cancer. The agency told consumers about interim results from a 10-year-study that indicated that patients taking Actos for a year or more had a significant increase in bladder cancer risk. Takeda [...]
